Nicholas Grund
Chief Commercial Officer at Akebia Therapeutics, Inc. (AKBA)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $118K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Feb 4SEC | AKBAAkebia Therapeutics, Inc. | Sell Plan | 53,585592,994 held (−8%) | $1.39 | $74K | -51.8% |
| Feb 4SEC | AKBAAkebia Therapeutics, Inc. | Sell Plan | 31,244561,750 held (−5%) | $1.39 | $43K | -51.8% |
- Sell
Chief Commercial Officer Nicholas Grund sold $74K of AKBA at $1.39 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Commercial Officer Nicholas Grund sold $43K of AKBA at $1.39 — pre-scheduled 10b5-1 plan sale.